nodes	percent_of_prediction	percent_of_DWPC	metapath
Zalcitabine—Gemcitabine—kidney cancer	0.425	1	CrCtD
Zalcitabine—Lamivudine—Gemcitabine—kidney cancer	0.126	0.558	CrCrCtD
Zalcitabine—SLC29A2—Gemcitabine—kidney cancer	0.0582	0.236	CbGbCtD
Zalcitabine—Cytarabine—Gemcitabine—kidney cancer	0.0522	0.232	CrCrCtD
Zalcitabine—Decitabine—Gemcitabine—kidney cancer	0.0472	0.21	CrCrCtD
Zalcitabine—SLC29A1—Gemcitabine—kidney cancer	0.0334	0.136	CbGbCtD
Zalcitabine—DCK—Gemcitabine—kidney cancer	0.031	0.126	CbGbCtD
Zalcitabine—CYP3A7-CYP3A51P—Temsirolimus—kidney cancer	0.0128	0.0521	CbGbCtD
Zalcitabine—CYP3A7—Temsirolimus—kidney cancer	0.0128	0.0521	CbGbCtD
Zalcitabine—CYP3A5—Temsirolimus—kidney cancer	0.00963	0.0391	CbGbCtD
Zalcitabine—CYP2D6—Temsirolimus—kidney cancer	0.0059	0.024	CbGbCtD
Zalcitabine—CYP3A4—Everolimus—kidney cancer	0.00556	0.0226	CbGbCtD
Zalcitabine—CYP3A7—Paclitaxel—kidney cancer	0.0044	0.0179	CbGbCtD
Zalcitabine—CYP3A7-CYP3A51P—Paclitaxel—kidney cancer	0.0044	0.0179	CbGbCtD
Zalcitabine—CYP3A7—Sorafenib—kidney cancer	0.00391	0.0159	CbGbCtD
Zalcitabine—CYP3A7-CYP3A51P—Sorafenib—kidney cancer	0.00391	0.0159	CbGbCtD
Zalcitabine—CYP3A7—Vincristine—kidney cancer	0.0038	0.0154	CbGbCtD
Zalcitabine—CYP3A7-CYP3A51P—Vincristine—kidney cancer	0.0038	0.0154	CbGbCtD
Zalcitabine—CYP3A4—Temsirolimus—kidney cancer	0.00375	0.0153	CbGbCtD
Zalcitabine—CYP3A5—Erlotinib—kidney cancer	0.00361	0.0147	CbGbCtD
Zalcitabine—CYP2C9—Capecitabine—kidney cancer	0.00354	0.0144	CbGbCtD
Zalcitabine—CYP3A5—Paclitaxel—kidney cancer	0.0033	0.0134	CbGbCtD
Zalcitabine—CYP3A7—Sunitinib—kidney cancer	0.00317	0.0129	CbGbCtD
Zalcitabine—CYP3A7-CYP3A51P—Sunitinib—kidney cancer	0.00317	0.0129	CbGbCtD
Zalcitabine—CYP2D6—Pazopanib—kidney cancer	0.0031	0.0126	CbGbCtD
Zalcitabine—CYP3A5—Sorafenib—kidney cancer	0.00293	0.0119	CbGbCtD
Zalcitabine—CYP3A5—Vincristine—kidney cancer	0.00285	0.0116	CbGbCtD
Zalcitabine—CYP3A5—Sunitinib—kidney cancer	0.00238	0.00966	CbGbCtD
Zalcitabine—CYP2C9—Paclitaxel—kidney cancer	0.00222	0.009	CbGbCtD
Zalcitabine—CYP2D6—Erlotinib—kidney cancer	0.00221	0.00899	CbGbCtD
Zalcitabine—CYP3A4—Pazopanib—kidney cancer	0.00197	0.00801	CbGbCtD
Zalcitabine—CYP2C9—Sorafenib—kidney cancer	0.00197	0.00799	CbGbCtD
Zalcitabine—CYP2D6—Sorafenib—kidney cancer	0.0018	0.00731	CbGbCtD
Zalcitabine—CYP2D6—Vinblastine—kidney cancer	0.00178	0.00722	CbGbCtD
Zalcitabine—CYP3A4—Erlotinib—kidney cancer	0.00141	0.00572	CbGbCtD
Zalcitabine—Lamivudine—PGK1—kidney cancer	0.00138	0.909	CrCbGaD
Zalcitabine—CYP3A4—Paclitaxel—kidney cancer	0.00129	0.00523	CbGbCtD
Zalcitabine—CYP3A4—Sorafenib—kidney cancer	0.00114	0.00465	CbGbCtD
Zalcitabine—CYP3A4—Vinblastine—kidney cancer	0.00113	0.00459	CbGbCtD
Zalcitabine—CYP3A4—Vincristine—kidney cancer	0.00111	0.00451	CbGbCtD
Zalcitabine—CYP2D6—Doxorubicin—kidney cancer	0.00109	0.00444	CbGbCtD
Zalcitabine—CYP3A4—Sunitinib—kidney cancer	0.000927	0.00377	CbGbCtD
Zalcitabine—CYP2C9—urine—kidney cancer	0.000731	0.0727	CbGeAlD
Zalcitabine—CYP3A4—Doxorubicin—kidney cancer	0.000694	0.00282	CbGbCtD
Zalcitabine—SLC29A2—cardiac atrium—kidney cancer	0.000664	0.066	CbGeAlD
Zalcitabine—CYP3A4—urine—kidney cancer	0.000558	0.0555	CbGeAlD
Zalcitabine—CYP2D6—urine—kidney cancer	0.000549	0.0546	CbGeAlD
Zalcitabine—SLC22A6—nephron tubule—kidney cancer	0.000506	0.0503	CbGeAlD
Zalcitabine—CYP3A7-CYP3A51P—nephron tubule—kidney cancer	0.000483	0.048	CbGeAlD
Zalcitabine—SLC22A7—renal system—kidney cancer	0.000476	0.0474	CbGeAlD
Zalcitabine—SLC22A7—kidney—kidney cancer	0.00046	0.0458	CbGeAlD
Zalcitabine—SLC22A7—cortex of kidney—kidney cancer	0.000448	0.0446	CbGeAlD
Zalcitabine—SLC22A6—cortex of kidney—kidney cancer	0.000433	0.043	CbGeAlD
Zalcitabine—DCK—Sirolimus—Everolimus—kidney cancer	0.000421	0.431	CbGdCrCtD
Zalcitabine—DCK—Sirolimus—Temsirolimus—kidney cancer	0.000421	0.431	CbGdCrCtD
Zalcitabine—CYP3A7-CYP3A51P—cortex of kidney—kidney cancer	0.000414	0.0411	CbGeAlD
Zalcitabine—DCK—nephron tubule—kidney cancer	0.000386	0.0384	CbGeAlD
Zalcitabine—SLC29A1—renal system—kidney cancer	0.000368	0.0365	CbGeAlD
Zalcitabine—SLC29A1—kidney—kidney cancer	0.000355	0.0353	CbGeAlD
Zalcitabine—SLC29A1—cortex of kidney—kidney cancer	0.000346	0.0344	CbGeAlD
Zalcitabine—DCK—cortex of kidney—kidney cancer	0.000331	0.0329	CbGeAlD
Zalcitabine—SLC29A1—gonad—kidney cancer	0.00033	0.0328	CbGeAlD
Zalcitabine—SLC29A1—cardiac atrium—kidney cancer	0.000329	0.0327	CbGeAlD
Zalcitabine—DCK—gonad—kidney cancer	0.000315	0.0313	CbGeAlD
Zalcitabine—DCK—cardiac atrium—kidney cancer	0.000314	0.0313	CbGeAlD
Zalcitabine—CYP3A5—nephron tubule—kidney cancer	0.0002	0.0199	CbGeAlD
Zalcitabine—CYP3A5—renal system—kidney cancer	0.000182	0.0181	CbGeAlD
Zalcitabine—CYP3A5—kidney—kidney cancer	0.000176	0.0175	CbGeAlD
Zalcitabine—CYP3A5—cortex of kidney—kidney cancer	0.000171	0.017	CbGeAlD
Zalcitabine—CYP3A4—renal system—kidney cancer	0.000136	0.0136	CbGeAlD
Zalcitabine—DCK—Epirubicin—Doxorubicin—kidney cancer	0.000136	0.139	CbGdCrCtD
Zalcitabine—CYP2D6—renal system—kidney cancer	0.000134	0.0134	CbGeAlD
Zalcitabine—CYP3A4—kidney—kidney cancer	0.000132	0.0131	CbGeAlD
Zalcitabine—CYP2D6—kidney—kidney cancer	0.00013	0.0129	CbGeAlD
Zalcitabine—Gemcitabine—ABCB1—kidney cancer	7.19e-05	0.0474	CrCbGaD
Zalcitabine—Lamivudine—ABCB1—kidney cancer	6.54e-05	0.0431	CrCbGaD
Zalcitabine—Vertigo—Paclitaxel—kidney cancer	2.31e-05	0.000299	CcSEcCtD
Zalcitabine—Syncope—Paclitaxel—kidney cancer	2.31e-05	0.000299	CcSEcCtD
Zalcitabine—Leukopenia—Paclitaxel—kidney cancer	2.3e-05	0.000298	CcSEcCtD
Zalcitabine—Hypersensitivity—Sunitinib—kidney cancer	2.3e-05	0.000298	CcSEcCtD
Zalcitabine—Decreased appetite—Vincristine—kidney cancer	2.3e-05	0.000298	CcSEcCtD
Zalcitabine—Pruritus—Sorafenib—kidney cancer	2.3e-05	0.000298	CcSEcCtD
Zalcitabine—Vomiting—Erlotinib—kidney cancer	2.29e-05	0.000297	CcSEcCtD
Zalcitabine—Musculoskeletal discomfort—Gemcitabine—kidney cancer	2.28e-05	0.000296	CcSEcCtD
Zalcitabine—Fatigue—Vincristine—kidney cancer	2.28e-05	0.000295	CcSEcCtD
Zalcitabine—Rash—Erlotinib—kidney cancer	2.27e-05	0.000295	CcSEcCtD
Zalcitabine—Dermatitis—Erlotinib—kidney cancer	2.27e-05	0.000294	CcSEcCtD
Zalcitabine—Palpitations—Paclitaxel—kidney cancer	2.27e-05	0.000294	CcSEcCtD
Zalcitabine—Hyponatraemia—Doxorubicin—kidney cancer	2.27e-05	0.000294	CcSEcCtD
Zalcitabine—Insomnia—Gemcitabine—kidney cancer	2.27e-05	0.000294	CcSEcCtD
Zalcitabine—Eye disorder—Capecitabine—kidney cancer	2.26e-05	0.000293	CcSEcCtD
Zalcitabine—Headache—Erlotinib—kidney cancer	2.26e-05	0.000293	CcSEcCtD
Zalcitabine—Tinnitus—Capecitabine—kidney cancer	2.26e-05	0.000293	CcSEcCtD
Zalcitabine—Loss of consciousness—Paclitaxel—kidney cancer	2.26e-05	0.000293	CcSEcCtD
Zalcitabine—Pain—Vincristine—kidney cancer	2.26e-05	0.000293	CcSEcCtD
Zalcitabine—Osteoarthritis—Doxorubicin—kidney cancer	2.26e-05	0.000293	CcSEcCtD
Zalcitabine—Pain in extremity—Doxorubicin—kidney cancer	2.26e-05	0.000293	CcSEcCtD
Zalcitabine—Gastrointestinal haemorrhage—Doxorubicin—kidney cancer	2.26e-05	0.000293	CcSEcCtD
Zalcitabine—Flushing—Capecitabine—kidney cancer	2.25e-05	0.000291	CcSEcCtD
Zalcitabine—Cough—Paclitaxel—kidney cancer	2.24e-05	0.000291	CcSEcCtD
Zalcitabine—Asthenia—Sunitinib—kidney cancer	2.24e-05	0.00029	CcSEcCtD
Zalcitabine—Dyspnoea—Gemcitabine—kidney cancer	2.23e-05	0.000289	CcSEcCtD
Zalcitabine—Somnolence—Gemcitabine—kidney cancer	2.23e-05	0.000289	CcSEcCtD
Zalcitabine—Convulsion—Paclitaxel—kidney cancer	2.23e-05	0.000289	CcSEcCtD
Zalcitabine—Migraine—Doxorubicin—kidney cancer	2.22e-05	0.000288	CcSEcCtD
Zalcitabine—Affect lability—Doxorubicin—kidney cancer	2.22e-05	0.000288	CcSEcCtD
Zalcitabine—Diarrhoea—Sorafenib—kidney cancer	2.22e-05	0.000288	CcSEcCtD
Zalcitabine—Hypertension—Paclitaxel—kidney cancer	2.22e-05	0.000288	CcSEcCtD
Zalcitabine—Pruritus—Sunitinib—kidney cancer	2.21e-05	0.000286	CcSEcCtD
Zalcitabine—Arthralgia—Paclitaxel—kidney cancer	2.19e-05	0.000284	CcSEcCtD
Zalcitabine—Myalgia—Paclitaxel—kidney cancer	2.19e-05	0.000284	CcSEcCtD
Zalcitabine—Anxiety—Paclitaxel—kidney cancer	2.18e-05	0.000283	CcSEcCtD
Zalcitabine—Decreased appetite—Gemcitabine—kidney cancer	2.18e-05	0.000282	CcSEcCtD
Zalcitabine—Hypersensitivity—Dactinomycin—kidney cancer	2.18e-05	0.000282	CcSEcCtD
Zalcitabine—Chills—Capecitabine—kidney cancer	2.17e-05	0.000282	CcSEcCtD
Zalcitabine—Arrhythmia—Capecitabine—kidney cancer	2.16e-05	0.00028	CcSEcCtD
Zalcitabine—Discomfort—Paclitaxel—kidney cancer	2.16e-05	0.00028	CcSEcCtD
Zalcitabine—Fatigue—Gemcitabine—kidney cancer	2.16e-05	0.00028	CcSEcCtD
Zalcitabine—Gastrointestinal pain—Vincristine—kidney cancer	2.16e-05	0.00028	CcSEcCtD
Zalcitabine—Dizziness—Sorafenib—kidney cancer	2.15e-05	0.000278	CcSEcCtD
Zalcitabine—Pain—Gemcitabine—kidney cancer	2.14e-05	0.000278	CcSEcCtD
Zalcitabine—Alopecia—Capecitabine—kidney cancer	2.14e-05	0.000277	CcSEcCtD
Zalcitabine—Dry mouth—Paclitaxel—kidney cancer	2.14e-05	0.000277	CcSEcCtD
Zalcitabine—Mood swings—Doxorubicin—kidney cancer	2.14e-05	0.000277	CcSEcCtD
Zalcitabine—Diarrhoea—Sunitinib—kidney cancer	2.14e-05	0.000277	CcSEcCtD
Zalcitabine—Ataxia—Doxorubicin—kidney cancer	2.12e-05	0.000275	CcSEcCtD
Zalcitabine—Asthenia—Dactinomycin—kidney cancer	2.12e-05	0.000275	CcSEcCtD
Zalcitabine—Confusional state—Paclitaxel—kidney cancer	2.12e-05	0.000274	CcSEcCtD
Zalcitabine—Blood creatinine increased—Doxorubicin—kidney cancer	2.12e-05	0.000274	CcSEcCtD
Zalcitabine—Oedema—Paclitaxel—kidney cancer	2.1e-05	0.000272	CcSEcCtD
Zalcitabine—Body temperature increased—Vincristine—kidney cancer	2.09e-05	0.000271	CcSEcCtD
Zalcitabine—Abdominal pain—Vincristine—kidney cancer	2.09e-05	0.000271	CcSEcCtD
Zalcitabine—Infection—Paclitaxel—kidney cancer	2.08e-05	0.00027	CcSEcCtD
Zalcitabine—Flatulence—Capecitabine—kidney cancer	2.08e-05	0.000269	CcSEcCtD
Zalcitabine—Dry skin—Doxorubicin—kidney cancer	2.07e-05	0.000268	CcSEcCtD
Zalcitabine—Dysgeusia—Capecitabine—kidney cancer	2.07e-05	0.000268	CcSEcCtD
Zalcitabine—Dizziness—Sunitinib—kidney cancer	2.07e-05	0.000268	CcSEcCtD
Zalcitabine—Feeling abnormal—Gemcitabine—kidney cancer	2.07e-05	0.000268	CcSEcCtD
Zalcitabine—Shock—Paclitaxel—kidney cancer	2.06e-05	0.000267	CcSEcCtD
Zalcitabine—Vomiting—Sorafenib—kidney cancer	2.06e-05	0.000267	CcSEcCtD
Zalcitabine—Abdominal pain upper—Doxorubicin—kidney cancer	2.06e-05	0.000267	CcSEcCtD
Zalcitabine—Hypokalaemia—Doxorubicin—kidney cancer	2.06e-05	0.000266	CcSEcCtD
Zalcitabine—Thrombocytopenia—Paclitaxel—kidney cancer	2.05e-05	0.000266	CcSEcCtD
Zalcitabine—Tachycardia—Paclitaxel—kidney cancer	2.05e-05	0.000265	CcSEcCtD
Zalcitabine—Rash—Sorafenib—kidney cancer	2.05e-05	0.000265	CcSEcCtD
Zalcitabine—Dermatitis—Sorafenib—kidney cancer	2.04e-05	0.000265	CcSEcCtD
Zalcitabine—Back pain—Capecitabine—kidney cancer	2.04e-05	0.000264	CcSEcCtD
Zalcitabine—Skin disorder—Paclitaxel—kidney cancer	2.04e-05	0.000264	CcSEcCtD
Zalcitabine—Headache—Sorafenib—kidney cancer	2.03e-05	0.000263	CcSEcCtD
Zalcitabine—Muscle spasms—Capecitabine—kidney cancer	2.03e-05	0.000263	CcSEcCtD
Zalcitabine—Hyperhidrosis—Paclitaxel—kidney cancer	2.03e-05	0.000263	CcSEcCtD
Zalcitabine—Diarrhoea—Dactinomycin—kidney cancer	2.02e-05	0.000262	CcSEcCtD
Zalcitabine—Nasopharyngitis—Doxorubicin—kidney cancer	2.02e-05	0.000262	CcSEcCtD
Zalcitabine—Anorexia—Paclitaxel—kidney cancer	2e-05	0.000259	CcSEcCtD
Zalcitabine—Gastritis—Doxorubicin—kidney cancer	2e-05	0.000259	CcSEcCtD
Zalcitabine—Muscular weakness—Doxorubicin—kidney cancer	1.99e-05	0.000258	CcSEcCtD
Zalcitabine—Vision blurred—Capecitabine—kidney cancer	1.99e-05	0.000258	CcSEcCtD
Zalcitabine—Vomiting—Sunitinib—kidney cancer	1.99e-05	0.000257	CcSEcCtD
Zalcitabine—Body temperature increased—Gemcitabine—kidney cancer	1.98e-05	0.000257	CcSEcCtD
Zalcitabine—Tremor—Capecitabine—kidney cancer	1.98e-05	0.000256	CcSEcCtD
Zalcitabine—Rash—Sunitinib—kidney cancer	1.97e-05	0.000255	CcSEcCtD
Zalcitabine—Dermatitis—Sunitinib—kidney cancer	1.97e-05	0.000255	CcSEcCtD
Zalcitabine—Abdominal distension—Doxorubicin—kidney cancer	1.96e-05	0.000255	CcSEcCtD
Zalcitabine—Ill-defined disorder—Capecitabine—kidney cancer	1.96e-05	0.000254	CcSEcCtD
Zalcitabine—Headache—Sunitinib—kidney cancer	1.96e-05	0.000253	CcSEcCtD
Zalcitabine—Dysphagia—Doxorubicin—kidney cancer	1.95e-05	0.000253	CcSEcCtD
Zalcitabine—Anaemia—Capecitabine—kidney cancer	1.95e-05	0.000253	CcSEcCtD
Zalcitabine—Hypersensitivity—Vincristine—kidney cancer	1.95e-05	0.000252	CcSEcCtD
Zalcitabine—Eosinophilia—Doxorubicin—kidney cancer	1.93e-05	0.00025	CcSEcCtD
Zalcitabine—Pancreatitis—Doxorubicin—kidney cancer	1.91e-05	0.000248	CcSEcCtD
Zalcitabine—Musculoskeletal discomfort—Paclitaxel—kidney cancer	1.91e-05	0.000248	CcSEcCtD
Zalcitabine—Malaise—Capecitabine—kidney cancer	1.9e-05	0.000246	CcSEcCtD
Zalcitabine—Insomnia—Paclitaxel—kidney cancer	1.9e-05	0.000246	CcSEcCtD
Zalcitabine—Vertigo—Capecitabine—kidney cancer	1.9e-05	0.000246	CcSEcCtD
Zalcitabine—Asthenia—Vincristine—kidney cancer	1.9e-05	0.000246	CcSEcCtD
Zalcitabine—Syncope—Capecitabine—kidney cancer	1.89e-05	0.000245	CcSEcCtD
Zalcitabine—Leukopenia—Capecitabine—kidney cancer	1.89e-05	0.000245	CcSEcCtD
Zalcitabine—Vomiting—Dactinomycin—kidney cancer	1.88e-05	0.000244	CcSEcCtD
Zalcitabine—Dyspnoea—Paclitaxel—kidney cancer	1.87e-05	0.000242	CcSEcCtD
Zalcitabine—Somnolence—Paclitaxel—kidney cancer	1.87e-05	0.000242	CcSEcCtD
Zalcitabine—Palpitations—Capecitabine—kidney cancer	1.86e-05	0.000242	CcSEcCtD
Zalcitabine—Rash—Dactinomycin—kidney cancer	1.86e-05	0.000242	CcSEcCtD
Zalcitabine—Loss of consciousness—Capecitabine—kidney cancer	1.85e-05	0.00024	CcSEcCtD
Zalcitabine—Dyspepsia—Paclitaxel—kidney cancer	1.85e-05	0.000239	CcSEcCtD
Zalcitabine—Cough—Capecitabine—kidney cancer	1.84e-05	0.000239	CcSEcCtD
Zalcitabine—Dysuria—Doxorubicin—kidney cancer	1.83e-05	0.000236	CcSEcCtD
Zalcitabine—Neutropenia—Doxorubicin—kidney cancer	1.83e-05	0.000236	CcSEcCtD
Zalcitabine—Decreased appetite—Paclitaxel—kidney cancer	1.82e-05	0.000236	CcSEcCtD
Zalcitabine—Hypertension—Capecitabine—kidney cancer	1.82e-05	0.000236	CcSEcCtD
Zalcitabine—Fatigue—Paclitaxel—kidney cancer	1.81e-05	0.000234	CcSEcCtD
Zalcitabine—Diarrhoea—Vincristine—kidney cancer	1.81e-05	0.000234	CcSEcCtD
Zalcitabine—Pollakiuria—Doxorubicin—kidney cancer	1.8e-05	0.000234	CcSEcCtD
Zalcitabine—Asthenia—Gemcitabine—kidney cancer	1.8e-05	0.000233	CcSEcCtD
Zalcitabine—Arthralgia—Capecitabine—kidney cancer	1.8e-05	0.000233	CcSEcCtD
Zalcitabine—Myalgia—Capecitabine—kidney cancer	1.8e-05	0.000233	CcSEcCtD
Zalcitabine—Pain—Paclitaxel—kidney cancer	1.79e-05	0.000232	CcSEcCtD
Zalcitabine—Anxiety—Capecitabine—kidney cancer	1.79e-05	0.000232	CcSEcCtD
Zalcitabine—Photosensitivity reaction—Doxorubicin—kidney cancer	1.78e-05	0.000231	CcSEcCtD
Zalcitabine—Discomfort—Capecitabine—kidney cancer	1.77e-05	0.00023	CcSEcCtD
Zalcitabine—Pruritus—Gemcitabine—kidney cancer	1.77e-05	0.00023	CcSEcCtD
Zalcitabine—Weight decreased—Doxorubicin—kidney cancer	1.77e-05	0.000229	CcSEcCtD
Zalcitabine—Hyperglycaemia—Doxorubicin—kidney cancer	1.76e-05	0.000228	CcSEcCtD
Zalcitabine—Dry mouth—Capecitabine—kidney cancer	1.76e-05	0.000228	CcSEcCtD
Zalcitabine—Dizziness—Vincristine—kidney cancer	1.75e-05	0.000226	CcSEcCtD
Zalcitabine—Confusional state—Capecitabine—kidney cancer	1.74e-05	0.000225	CcSEcCtD
Zalcitabine—Feeling abnormal—Paclitaxel—kidney cancer	1.73e-05	0.000224	CcSEcCtD
Zalcitabine—Oedema—Capecitabine—kidney cancer	1.72e-05	0.000223	CcSEcCtD
Zalcitabine—Gastrointestinal pain—Paclitaxel—kidney cancer	1.72e-05	0.000222	CcSEcCtD
Zalcitabine—Diarrhoea—Gemcitabine—kidney cancer	1.71e-05	0.000222	CcSEcCtD
Zalcitabine—Infection—Capecitabine—kidney cancer	1.71e-05	0.000222	CcSEcCtD
Zalcitabine—Neuropathy peripheral—Doxorubicin—kidney cancer	1.71e-05	0.000221	CcSEcCtD
Zalcitabine—Jaundice—Doxorubicin—kidney cancer	1.7e-05	0.00022	CcSEcCtD
Zalcitabine—Shock—Capecitabine—kidney cancer	1.69e-05	0.000219	CcSEcCtD
Zalcitabine—Thrombocytopenia—Capecitabine—kidney cancer	1.69e-05	0.000218	CcSEcCtD
Zalcitabine—Tachycardia—Capecitabine—kidney cancer	1.68e-05	0.000218	CcSEcCtD
Zalcitabine—Vomiting—Vincristine—kidney cancer	1.68e-05	0.000218	CcSEcCtD
Zalcitabine—Skin disorder—Capecitabine—kidney cancer	1.67e-05	0.000217	CcSEcCtD
Zalcitabine—Urticaria—Paclitaxel—kidney cancer	1.67e-05	0.000216	CcSEcCtD
Zalcitabine—Rash—Vincristine—kidney cancer	1.67e-05	0.000216	CcSEcCtD
Zalcitabine—Hyperhidrosis—Capecitabine—kidney cancer	1.66e-05	0.000216	CcSEcCtD
Zalcitabine—Dermatitis—Vincristine—kidney cancer	1.66e-05	0.000216	CcSEcCtD
Zalcitabine—Body temperature increased—Paclitaxel—kidney cancer	1.66e-05	0.000215	CcSEcCtD
Zalcitabine—Abdominal pain—Paclitaxel—kidney cancer	1.66e-05	0.000215	CcSEcCtD
Zalcitabine—Headache—Vincristine—kidney cancer	1.65e-05	0.000214	CcSEcCtD
Zalcitabine—Epistaxis—Doxorubicin—kidney cancer	1.64e-05	0.000213	CcSEcCtD
Zalcitabine—Anorexia—Capecitabine—kidney cancer	1.64e-05	0.000213	CcSEcCtD
Zalcitabine—Sinusitis—Doxorubicin—kidney cancer	1.63e-05	0.000212	CcSEcCtD
Zalcitabine—Vomiting—Gemcitabine—kidney cancer	1.59e-05	0.000206	CcSEcCtD
Zalcitabine—Rash—Gemcitabine—kidney cancer	1.58e-05	0.000205	CcSEcCtD
Zalcitabine—Dermatitis—Gemcitabine—kidney cancer	1.58e-05	0.000205	CcSEcCtD
Zalcitabine—Headache—Gemcitabine—kidney cancer	1.57e-05	0.000203	CcSEcCtD
Zalcitabine—Musculoskeletal discomfort—Capecitabine—kidney cancer	1.57e-05	0.000203	CcSEcCtD
Zalcitabine—Rhinitis—Doxorubicin—kidney cancer	1.57e-05	0.000203	CcSEcCtD
Zalcitabine—Hepatitis—Doxorubicin—kidney cancer	1.56e-05	0.000202	CcSEcCtD
Zalcitabine—Insomnia—Capecitabine—kidney cancer	1.56e-05	0.000202	CcSEcCtD
Zalcitabine—Pharyngitis—Doxorubicin—kidney cancer	1.55e-05	0.000201	CcSEcCtD
Zalcitabine—Hypersensitivity—Paclitaxel—kidney cancer	1.55e-05	0.0002	CcSEcCtD
Zalcitabine—Dyspnoea—Capecitabine—kidney cancer	1.54e-05	0.000199	CcSEcCtD
Zalcitabine—Dyspepsia—Capecitabine—kidney cancer	1.52e-05	0.000196	CcSEcCtD
Zalcitabine—Visual impairment—Doxorubicin—kidney cancer	1.51e-05	0.000195	CcSEcCtD
Zalcitabine—Asthenia—Paclitaxel—kidney cancer	1.51e-05	0.000195	CcSEcCtD
Zalcitabine—Decreased appetite—Capecitabine—kidney cancer	1.5e-05	0.000194	CcSEcCtD
Zalcitabine—Fatigue—Capecitabine—kidney cancer	1.48e-05	0.000192	CcSEcCtD
Zalcitabine—Pruritus—Paclitaxel—kidney cancer	1.48e-05	0.000192	CcSEcCtD
Zalcitabine—Pain—Capecitabine—kidney cancer	1.47e-05	0.000191	CcSEcCtD
Zalcitabine—Eye disorder—Doxorubicin—kidney cancer	1.46e-05	0.000189	CcSEcCtD
Zalcitabine—Tinnitus—Doxorubicin—kidney cancer	1.46e-05	0.000189	CcSEcCtD
Zalcitabine—Flushing—Doxorubicin—kidney cancer	1.45e-05	0.000188	CcSEcCtD
Zalcitabine—Diarrhoea—Paclitaxel—kidney cancer	1.44e-05	0.000186	CcSEcCtD
Zalcitabine—Feeling abnormal—Capecitabine—kidney cancer	1.42e-05	0.000184	CcSEcCtD
Zalcitabine—Gastrointestinal pain—Capecitabine—kidney cancer	1.41e-05	0.000182	CcSEcCtD
Zalcitabine—Chills—Doxorubicin—kidney cancer	1.4e-05	0.000182	CcSEcCtD
Zalcitabine—Arrhythmia—Doxorubicin—kidney cancer	1.4e-05	0.000181	CcSEcCtD
Zalcitabine—Dizziness—Paclitaxel—kidney cancer	1.39e-05	0.00018	CcSEcCtD
Zalcitabine—Alopecia—Doxorubicin—kidney cancer	1.38e-05	0.000179	CcSEcCtD
Zalcitabine—Urticaria—Capecitabine—kidney cancer	1.37e-05	0.000177	CcSEcCtD
Zalcitabine—Body temperature increased—Capecitabine—kidney cancer	1.36e-05	0.000176	CcSEcCtD
Zalcitabine—Abdominal pain—Capecitabine—kidney cancer	1.36e-05	0.000176	CcSEcCtD
Zalcitabine—Flatulence—Doxorubicin—kidney cancer	1.34e-05	0.000174	CcSEcCtD
Zalcitabine—Tension—Doxorubicin—kidney cancer	1.33e-05	0.000173	CcSEcCtD
Zalcitabine—Vomiting—Paclitaxel—kidney cancer	1.33e-05	0.000173	CcSEcCtD
Zalcitabine—Dysgeusia—Doxorubicin—kidney cancer	1.33e-05	0.000173	CcSEcCtD
Zalcitabine—Rash—Paclitaxel—kidney cancer	1.32e-05	0.000171	CcSEcCtD
Zalcitabine—Dermatitis—Paclitaxel—kidney cancer	1.32e-05	0.000171	CcSEcCtD
Zalcitabine—Nervousness—Doxorubicin—kidney cancer	1.32e-05	0.000171	CcSEcCtD
Zalcitabine—Back pain—Doxorubicin—kidney cancer	1.32e-05	0.00017	CcSEcCtD
Zalcitabine—Headache—Paclitaxel—kidney cancer	1.31e-05	0.00017	CcSEcCtD
Zalcitabine—Muscle spasms—Doxorubicin—kidney cancer	1.31e-05	0.000169	CcSEcCtD
Zalcitabine—Vision blurred—Doxorubicin—kidney cancer	1.28e-05	0.000166	CcSEcCtD
Zalcitabine—Hypersensitivity—Capecitabine—kidney cancer	1.27e-05	0.000164	CcSEcCtD
Zalcitabine—Ill-defined disorder—Doxorubicin—kidney cancer	1.26e-05	0.000163	CcSEcCtD
Zalcitabine—Anaemia—Doxorubicin—kidney cancer	1.26e-05	0.000163	CcSEcCtD
Zalcitabine—Agitation—Doxorubicin—kidney cancer	1.25e-05	0.000162	CcSEcCtD
Zalcitabine—Asthenia—Capecitabine—kidney cancer	1.24e-05	0.00016	CcSEcCtD
Zalcitabine—Malaise—Doxorubicin—kidney cancer	1.23e-05	0.000159	CcSEcCtD
Zalcitabine—Vertigo—Doxorubicin—kidney cancer	1.22e-05	0.000158	CcSEcCtD
Zalcitabine—Syncope—Doxorubicin—kidney cancer	1.22e-05	0.000158	CcSEcCtD
Zalcitabine—Pruritus—Capecitabine—kidney cancer	1.22e-05	0.000158	CcSEcCtD
Zalcitabine—Leukopenia—Doxorubicin—kidney cancer	1.22e-05	0.000158	CcSEcCtD
Zalcitabine—Palpitations—Doxorubicin—kidney cancer	1.2e-05	0.000156	CcSEcCtD
Zalcitabine—Loss of consciousness—Doxorubicin—kidney cancer	1.2e-05	0.000155	CcSEcCtD
Zalcitabine—Cough—Doxorubicin—kidney cancer	1.19e-05	0.000154	CcSEcCtD
Zalcitabine—Convulsion—Doxorubicin—kidney cancer	1.18e-05	0.000153	CcSEcCtD
Zalcitabine—Diarrhoea—Capecitabine—kidney cancer	1.18e-05	0.000153	CcSEcCtD
Zalcitabine—CYP3A7—Biological oxidations—POMC—kidney cancer	1.18e-05	0.000848	CbGpPWpGaD
Zalcitabine—Hypertension—Doxorubicin—kidney cancer	1.17e-05	0.000152	CcSEcCtD
Zalcitabine—Arthralgia—Doxorubicin—kidney cancer	1.16e-05	0.00015	CcSEcCtD
Zalcitabine—Myalgia—Doxorubicin—kidney cancer	1.16e-05	0.00015	CcSEcCtD
Zalcitabine—Anxiety—Doxorubicin—kidney cancer	1.15e-05	0.000149	CcSEcCtD
Zalcitabine—Discomfort—Doxorubicin—kidney cancer	1.14e-05	0.000148	CcSEcCtD
Zalcitabine—CYP3A5—Biological oxidations—CYP1A1—kidney cancer	1.14e-05	0.000822	CbGpPWpGaD
Zalcitabine—Dizziness—Capecitabine—kidney cancer	1.14e-05	0.000148	CcSEcCtD
Zalcitabine—CYP2D6—Phase 1 - Functionalization of compounds—POMC—kidney cancer	1.14e-05	0.00082	CbGpPWpGaD
Zalcitabine—Dry mouth—Doxorubicin—kidney cancer	1.13e-05	0.000147	CcSEcCtD
Zalcitabine—CYP2C9—Phase 1 - Functionalization of compounds—POMC—kidney cancer	1.13e-05	0.000813	CbGpPWpGaD
Zalcitabine—DCK—Metabolism—ACHE—kidney cancer	1.13e-05	0.000812	CbGpPWpGaD
Zalcitabine—DCK—Metabolism—GSTT1—kidney cancer	1.13e-05	0.000812	CbGpPWpGaD
Zalcitabine—CYP3A5—Metapathway biotransformation—CYP1A1—kidney cancer	1.12e-05	0.000811	CbGpPWpGaD
Zalcitabine—Confusional state—Doxorubicin—kidney cancer	1.12e-05	0.000145	CcSEcCtD
Zalcitabine—Oedema—Doxorubicin—kidney cancer	1.11e-05	0.000144	CcSEcCtD
Zalcitabine—CYP3A7—Metabolism—CCBL1—kidney cancer	1.11e-05	0.0008	CbGpPWpGaD
Zalcitabine—CYP3A43—Metabolism—ACHE—kidney cancer	1.11e-05	0.0008	CbGpPWpGaD
Zalcitabine—CYP3A43—Metabolism—GSTT1—kidney cancer	1.11e-05	0.0008	CbGpPWpGaD
Zalcitabine—Infection—Doxorubicin—kidney cancer	1.1e-05	0.000143	CcSEcCtD
Zalcitabine—CYP2C9—Metabolism of lipids and lipoproteins—GLIPR1—kidney cancer	1.1e-05	0.000793	CbGpPWpGaD
Zalcitabine—Vomiting—Capecitabine—kidney cancer	1.09e-05	0.000142	CcSEcCtD
Zalcitabine—Shock—Doxorubicin—kidney cancer	1.09e-05	0.000141	CcSEcCtD
Zalcitabine—Thrombocytopenia—Doxorubicin—kidney cancer	1.09e-05	0.000141	CcSEcCtD
Zalcitabine—Rash—Capecitabine—kidney cancer	1.09e-05	0.000141	CcSEcCtD
Zalcitabine—Dermatitis—Capecitabine—kidney cancer	1.08e-05	0.000141	CcSEcCtD
Zalcitabine—Tachycardia—Doxorubicin—kidney cancer	1.08e-05	0.00014	CcSEcCtD
Zalcitabine—Headache—Capecitabine—kidney cancer	1.08e-05	0.00014	CcSEcCtD
Zalcitabine—Skin disorder—Doxorubicin—kidney cancer	1.08e-05	0.00014	CcSEcCtD
Zalcitabine—Hyperhidrosis—Doxorubicin—kidney cancer	1.07e-05	0.000139	CcSEcCtD
Zalcitabine—SLC22A7—Transmembrane transport of small molecules—ABCB1—kidney cancer	1.07e-05	0.00077	CbGpPWpGaD
Zalcitabine—DCK—Metabolism—SCARB1—kidney cancer	1.07e-05	0.000769	CbGpPWpGaD
Zalcitabine—SLC29A1—Transmembrane transport of small molecules—RAF1—kidney cancer	1.06e-05	0.000765	CbGpPWpGaD
Zalcitabine—Anorexia—Doxorubicin—kidney cancer	1.06e-05	0.000137	CcSEcCtD
Zalcitabine—DCK—Metabolism—PTGS1—kidney cancer	1.06e-05	0.000761	CbGpPWpGaD
Zalcitabine—CYP3A43—Metabolism—SCARB1—kidney cancer	1.05e-05	0.000757	CbGpPWpGaD
Zalcitabine—CYP3A43—Metabolism—PTGS1—kidney cancer	1.04e-05	0.000749	CbGpPWpGaD
Zalcitabine—DCK—Metabolism—PSMD7—kidney cancer	1.03e-05	0.000746	CbGpPWpGaD
Zalcitabine—CYP3A43—Metabolism—PSMD7—kidney cancer	1.02e-05	0.000735	CbGpPWpGaD
Zalcitabine—Musculoskeletal discomfort—Doxorubicin—kidney cancer	1.01e-05	0.000131	CcSEcCtD
Zalcitabine—Insomnia—Doxorubicin—kidney cancer	1e-05	0.00013	CcSEcCtD
Zalcitabine—CYP3A5—Metabolism—ACY1—kidney cancer	1e-05	0.000723	CbGpPWpGaD
Zalcitabine—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—kidney cancer	9.98e-06	0.000719	CbGpPWpGaD
Zalcitabine—Dyspnoea—Doxorubicin—kidney cancer	9.89e-06	0.000128	CcSEcCtD
Zalcitabine—Somnolence—Doxorubicin—kidney cancer	9.87e-06	0.000128	CcSEcCtD
Zalcitabine—SLC22A6—Transmembrane transport of small molecules—SLC5A5—kidney cancer	9.83e-06	0.000709	CbGpPWpGaD
Zalcitabine—DCK—Metabolism—BCHE—kidney cancer	9.81e-06	0.000707	CbGpPWpGaD
Zalcitabine—Dyspepsia—Doxorubicin—kidney cancer	9.77e-06	0.000127	CcSEcCtD
Zalcitabine—DCK—Metabolism—SLC5A5—kidney cancer	9.69e-06	0.000699	CbGpPWpGaD
Zalcitabine—CYP3A43—Metabolism—BCHE—kidney cancer	9.66e-06	0.000697	CbGpPWpGaD
Zalcitabine—Decreased appetite—Doxorubicin—kidney cancer	9.65e-06	0.000125	CcSEcCtD
Zalcitabine—CYP3A7—Metabolism—PPAT—kidney cancer	9.62e-06	0.000693	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—GLIPR1—kidney cancer	9.62e-06	0.000693	CbGpPWpGaD
Zalcitabine—Fatigue—Doxorubicin—kidney cancer	9.57e-06	0.000124	CcSEcCtD
Zalcitabine—CYP3A43—Metabolism—SLC5A5—kidney cancer	9.54e-06	0.000688	CbGpPWpGaD
Zalcitabine—SLC22A6—Transmembrane transport of small molecules—SLC2A1—kidney cancer	9.49e-06	0.000684	CbGpPWpGaD
Zalcitabine—Pain—Doxorubicin—kidney cancer	9.49e-06	0.000123	CcSEcCtD
Zalcitabine—DCK—Metabolism—SLC2A1—kidney cancer	9.36e-06	0.000675	CbGpPWpGaD
Zalcitabine—CYP2D6—Biological oxidations—GSTP1—kidney cancer	9.31e-06	0.000671	CbGpPWpGaD
Zalcitabine—CYP2C9—Biological oxidations—GSTP1—kidney cancer	9.23e-06	0.000665	CbGpPWpGaD
Zalcitabine—CYP3A43—Metabolism—SLC2A1—kidney cancer	9.22e-06	0.000664	CbGpPWpGaD
Zalcitabine—CYP2D6—Metapathway biotransformation—GSTP1—kidney cancer	9.18e-06	0.000662	CbGpPWpGaD
Zalcitabine—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—kidney cancer	9.18e-06	0.000662	CbGpPWpGaD
Zalcitabine—Feeling abnormal—Doxorubicin—kidney cancer	9.15e-06	0.000118	CcSEcCtD
Zalcitabine—CYP2C9—Metapathway biotransformation—GSTP1—kidney cancer	9.1e-06	0.000656	CbGpPWpGaD
Zalcitabine—Gastrointestinal pain—Doxorubicin—kidney cancer	9.08e-06	0.000118	CcSEcCtD
Zalcitabine—CYP3A7—Metabolism—APRT—kidney cancer	8.94e-06	0.000645	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—FH—kidney cancer	8.94e-06	0.000645	CbGpPWpGaD
Zalcitabine—Urticaria—Doxorubicin—kidney cancer	8.82e-06	0.000114	CcSEcCtD
Zalcitabine—CYP3A4—Biological oxidations—GSTT1—kidney cancer	8.78e-06	0.000633	CbGpPWpGaD
Zalcitabine—Body temperature increased—Doxorubicin—kidney cancer	8.77e-06	0.000114	CcSEcCtD
Zalcitabine—Abdominal pain—Doxorubicin—kidney cancer	8.77e-06	0.000114	CcSEcCtD
Zalcitabine—CYP2D6—Biological oxidations—GSTM1—kidney cancer	8.55e-06	0.000617	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—PDHB—kidney cancer	8.53e-06	0.000615	CbGpPWpGaD
Zalcitabine—CYP3A5—Biological oxidations—POMC—kidney cancer	8.5e-06	0.000613	CbGpPWpGaD
Zalcitabine—CYP2C9—Biological oxidations—GSTM1—kidney cancer	8.48e-06	0.000611	CbGpPWpGaD
Zalcitabine—CYP2D6—Metapathway biotransformation—GSTM1—kidney cancer	8.44e-06	0.000608	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—GPC3—kidney cancer	8.41e-06	0.000606	CbGpPWpGaD
Zalcitabine—CYP2C9—Metapathway biotransformation—GSTM1—kidney cancer	8.36e-06	0.000603	CbGpPWpGaD
Zalcitabine—CYP3A4—Biological oxidations—PTGS1—kidney cancer	8.23e-06	0.000593	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—CA2—kidney cancer	8.18e-06	0.00059	CbGpPWpGaD
Zalcitabine—Hypersensitivity—Doxorubicin—kidney cancer	8.18e-06	0.000106	CcSEcCtD
Zalcitabine—CYP2D6—Biological oxidations—CYP1A1—kidney cancer	8.11e-06	0.000584	CbGpPWpGaD
Zalcitabine—CYP2C9—Biological oxidations—CYP1A1—kidney cancer	8.04e-06	0.000579	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—CCBL1—kidney cancer	8.02e-06	0.000578	CbGpPWpGaD
Zalcitabine—CYP2D6—Metapathway biotransformation—CYP1A1—kidney cancer	8e-06	0.000576	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—ALAD—kidney cancer	7.97e-06	0.000574	CbGpPWpGaD
Zalcitabine—Asthenia—Doxorubicin—kidney cancer	7.96e-06	0.000103	CcSEcCtD
Zalcitabine—CYP2C9—Metapathway biotransformation—CYP1A1—kidney cancer	7.93e-06	0.000571	CbGpPWpGaD
Zalcitabine—Pruritus—Doxorubicin—kidney cancer	7.85e-06	0.000102	CcSEcCtD
Zalcitabine—DCK—Metabolism—GSTP1—kidney cancer	7.81e-06	0.000563	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—ST3GAL2—kidney cancer	7.78e-06	0.000561	CbGpPWpGaD
Zalcitabine—CYP3A43—Metabolism—GSTP1—kidney cancer	7.69e-06	0.000554	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—ALDH1A1—kidney cancer	7.6e-06	0.000548	CbGpPWpGaD
Zalcitabine—Diarrhoea—Doxorubicin—kidney cancer	7.59e-06	9.84e-05	CcSEcCtD
Zalcitabine—SLC22A6—Transmembrane transport of small molecules—ABCB1—kidney cancer	7.5e-06	0.00054	CbGpPWpGaD
Zalcitabine—CYP3A4—Phase 1 - Functionalization of compounds—POMC—kidney cancer	7.44e-06	0.000536	CbGpPWpGaD
Zalcitabine—DCK—Metabolism—ABCB1—kidney cancer	7.39e-06	0.000533	CbGpPWpGaD
Zalcitabine—Dizziness—Doxorubicin—kidney cancer	7.34e-06	9.51e-05	CcSEcCtD
Zalcitabine—CYP3A7—Metabolism—PGK1—kidney cancer	7.29e-06	0.000525	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—SLC5A3—kidney cancer	7.29e-06	0.000525	CbGpPWpGaD
Zalcitabine—CYP3A43—Metabolism—ABCB1—kidney cancer	7.28e-06	0.000525	CbGpPWpGaD
Zalcitabine—DCK—Metabolism—GSTM1—kidney cancer	7.17e-06	0.000517	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—LDHB—kidney cancer	7.15e-06	0.000515	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—ACY1—kidney cancer	7.13e-06	0.000514	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—ACY1—kidney cancer	7.07e-06	0.00051	CbGpPWpGaD
Zalcitabine—CYP3A43—Metabolism—GSTM1—kidney cancer	7.06e-06	0.000509	CbGpPWpGaD
Zalcitabine—Vomiting—Doxorubicin—kidney cancer	7.06e-06	9.14e-05	CcSEcCtD
Zalcitabine—Rash—Doxorubicin—kidney cancer	7e-06	9.07e-05	CcSEcCtD
Zalcitabine—Dermatitis—Doxorubicin—kidney cancer	6.99e-06	9.06e-05	CcSEcCtD
Zalcitabine—Headache—Doxorubicin—kidney cancer	6.95e-06	9.01e-05	CcSEcCtD
Zalcitabine—CYP3A5—Metabolism—GLIPR1—kidney cancer	6.95e-06	0.000501	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—PPAT—kidney cancer	6.95e-06	0.000501	CbGpPWpGaD
Zalcitabine—DCK—Metabolism—CYP1A1—kidney cancer	6.8e-06	0.00049	CbGpPWpGaD
Zalcitabine—CYP3A43—Metabolism—CYP1A1—kidney cancer	6.7e-06	0.000483	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—APRT—kidney cancer	6.46e-06	0.000466	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—FH—kidney cancer	6.46e-06	0.000466	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—CA9—kidney cancer	6.2e-06	0.000447	CbGpPWpGaD
Zalcitabine—CYP3A4—Biological oxidations—GSTP1—kidney cancer	6.08e-06	0.000439	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—GPC3—kidney cancer	6.08e-06	0.000438	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—PDHB—kidney cancer	6.06e-06	0.000437	CbGpPWpGaD
Zalcitabine—CYP2D6—Biological oxidations—POMC—kidney cancer	6.05e-06	0.000436	CbGpPWpGaD
Zalcitabine—SLC22A7—Transmembrane transport of small molecules—RAF1—kidney cancer	6.04e-06	0.000436	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism of lipids and lipoproteins—CRABP1—kidney cancer	6.03e-06	0.000435	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—PDHB—kidney cancer	6.01e-06	0.000433	CbGpPWpGaD
Zalcitabine—CYP3A4—Metapathway biotransformation—GSTP1—kidney cancer	6e-06	0.000433	CbGpPWpGaD
Zalcitabine—CYP2C9—Biological oxidations—POMC—kidney cancer	5.99e-06	0.000432	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—CA2—kidney cancer	5.91e-06	0.000426	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—ALAD—kidney cancer	5.76e-06	0.000415	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—CCBL1—kidney cancer	5.7e-06	0.000411	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—CCBL1—kidney cancer	5.65e-06	0.000407	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—ST3GAL2—kidney cancer	5.62e-06	0.000405	CbGpPWpGaD
Zalcitabine—CYP3A4—Biological oxidations—GSTM1—kidney cancer	5.59e-06	0.000403	CbGpPWpGaD
Zalcitabine—CYP3A4—Metapathway biotransformation—GSTM1—kidney cancer	5.51e-06	0.000398	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—ALDH1A1—kidney cancer	5.5e-06	0.000396	CbGpPWpGaD
Zalcitabine—CYP3A4—Biological oxidations—CYP1A1—kidney cancer	5.3e-06	0.000382	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—CRABP1—kidney cancer	5.27e-06	0.00038	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—PGK1—kidney cancer	5.27e-06	0.00038	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—SLC5A3—kidney cancer	5.27e-06	0.00038	CbGpPWpGaD
Zalcitabine—CYP3A4—Metapathway biotransformation—CYP1A1—kidney cancer	5.23e-06	0.000377	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—LDHB—kidney cancer	5.17e-06	0.000372	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism of lipids and lipoproteins—ACHE—kidney cancer	5.11e-06	0.000368	CbGpPWpGaD
Zalcitabine—DCK—Metabolism—POMC—kidney cancer	5.07e-06	0.000366	CbGpPWpGaD
Zalcitabine—CYP3A43—Metabolism—POMC—kidney cancer	4.99e-06	0.00036	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—PPAT—kidney cancer	4.94e-06	0.000356	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—GLIPR1—kidney cancer	4.94e-06	0.000356	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—PPAT—kidney cancer	4.9e-06	0.000353	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—GLIPR1—kidney cancer	4.9e-06	0.000353	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—ITPR2—kidney cancer	4.9e-06	0.000353	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism of lipids and lipoproteins—SCARB1—kidney cancer	4.84e-06	0.000349	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS1—kidney cancer	4.79e-06	0.000345	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—ACY1—kidney cancer	4.66e-06	0.000336	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—FH—kidney cancer	4.6e-06	0.000331	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—APRT—kidney cancer	4.6e-06	0.000331	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—FH—kidney cancer	4.56e-06	0.000328	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—APRT—kidney cancer	4.56e-06	0.000328	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—CA9—kidney cancer	4.48e-06	0.000323	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—GSTT1—kidney cancer	4.47e-06	0.000322	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—ACHE—kidney cancer	4.47e-06	0.000322	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism of lipids and lipoproteins—BCHE—kidney cancer	4.45e-06	0.000321	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—GPC3—kidney cancer	4.32e-06	0.000311	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—GPC3—kidney cancer	4.28e-06	0.000309	CbGpPWpGaD
Zalcitabine—SLC22A6—Transmembrane transport of small molecules—RAF1—kidney cancer	4.24e-06	0.000306	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—SCARB1—kidney cancer	4.23e-06	0.000305	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—CA2—kidney cancer	4.2e-06	0.000303	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—PTGS1—kidney cancer	4.19e-06	0.000302	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—CA2—kidney cancer	4.17e-06	0.0003	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—PSMD7—kidney cancer	4.11e-06	0.000296	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—ALAD—kidney cancer	4.1e-06	0.000295	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—ALAD—kidney cancer	4.06e-06	0.000293	CbGpPWpGaD
Zalcitabine—DCK—Metabolism—PTGS2—kidney cancer	4.04e-06	0.000292	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—ST3GAL2—kidney cancer	4e-06	0.000288	CbGpPWpGaD
Zalcitabine—CYP3A43—Metabolism—PTGS2—kidney cancer	3.98e-06	0.000287	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—PDHB—kidney cancer	3.96e-06	0.000286	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—ST3GAL2—kidney cancer	3.96e-06	0.000286	CbGpPWpGaD
Zalcitabine—CYP3A4—Biological oxidations—POMC—kidney cancer	3.95e-06	0.000285	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—ALDH1A1—kidney cancer	3.91e-06	0.000282	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—BCHE—kidney cancer	3.89e-06	0.000281	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—ALDH1A1—kidney cancer	3.87e-06	0.000279	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—SLC5A5—kidney cancer	3.84e-06	0.000277	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—CRABP1—kidney cancer	3.81e-06	0.000275	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—SLC5A3—kidney cancer	3.75e-06	0.00027	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—PGK1—kidney cancer	3.75e-06	0.00027	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—CCBL1—kidney cancer	3.73e-06	0.000269	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—PGK1—kidney cancer	3.71e-06	0.000268	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—SLC5A3—kidney cancer	3.71e-06	0.000268	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—SLC2A1—kidney cancer	3.71e-06	0.000268	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—LDHB—kidney cancer	3.67e-06	0.000265	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—LDHB—kidney cancer	3.64e-06	0.000263	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—ITPR2—kidney cancer	3.54e-06	0.000255	CbGpPWpGaD
Zalcitabine—DCK—Metabolism—PTEN—kidney cancer	3.53e-06	0.000254	CbGpPWpGaD
Zalcitabine—CYP3A43—Metabolism—PTEN—kidney cancer	3.47e-06	0.00025	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—GLIPR1—kidney cancer	3.23e-06	0.000233	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—PPAT—kidney cancer	3.23e-06	0.000233	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—ACHE—kidney cancer	3.23e-06	0.000233	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—GSTT1—kidney cancer	3.23e-06	0.000233	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—CA9—kidney cancer	3.19e-06	0.00023	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—CA9—kidney cancer	3.16e-06	0.000228	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—GSTP1—kidney cancer	3.1e-06	0.000223	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	3.09e-06	0.000223	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—SCARB1—kidney cancer	3.06e-06	0.00022	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—PTGS1—kidney cancer	3.03e-06	0.000218	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—FH—kidney cancer	3e-06	0.000217	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—APRT—kidney cancer	3e-06	0.000217	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—PSMD7—kidney cancer	2.97e-06	0.000214	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—ABCB1—kidney cancer	2.93e-06	0.000211	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—GSTM1—kidney cancer	2.85e-06	0.000205	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—GPC3—kidney cancer	2.82e-06	0.000204	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—BCHE—kidney cancer	2.81e-06	0.000203	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—SLC5A5—kidney cancer	2.78e-06	0.0002	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—CA2—kidney cancer	2.75e-06	0.000198	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—CRABP1—kidney cancer	2.71e-06	0.000195	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—CYP1A1—kidney cancer	2.7e-06	0.000194	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—CRABP1—kidney cancer	2.69e-06	0.000194	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—SLC2A1—kidney cancer	2.68e-06	0.000193	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—ALAD—kidney cancer	2.68e-06	0.000193	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—ST3GAL2—kidney cancer	2.61e-06	0.000188	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—ALDH1A1—kidney cancer	2.55e-06	0.000184	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—ITPR2—kidney cancer	2.52e-06	0.000182	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—ITPR2—kidney cancer	2.5e-06	0.00018	CbGpPWpGaD
Zalcitabine—DCK—Metabolism—PIK3CA—kidney cancer	2.49e-06	0.000179	CbGpPWpGaD
Zalcitabine—CYP3A43—Metabolism—PIK3CA—kidney cancer	2.45e-06	0.000177	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—PGK1—kidney cancer	2.45e-06	0.000177	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—SLC5A3—kidney cancer	2.45e-06	0.000177	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—LDHB—kidney cancer	2.4e-06	0.000173	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism of lipids and lipoproteins—POMC—kidney cancer	2.3e-06	0.000166	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—ACHE—kidney cancer	2.3e-06	0.000166	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—GSTT1—kidney cancer	2.3e-06	0.000166	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—GSTT1—kidney cancer	2.28e-06	0.000164	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—ACHE—kidney cancer	2.28e-06	0.000164	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—GSTP1—kidney cancer	2.24e-06	0.000161	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—SCARB1—kidney cancer	2.17e-06	0.000157	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—SCARB1—kidney cancer	2.15e-06	0.000155	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—PTGS1—kidney cancer	2.15e-06	0.000155	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—PTGS1—kidney cancer	2.13e-06	0.000154	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—ABCB1—kidney cancer	2.12e-06	0.000153	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—PSMD7—kidney cancer	2.11e-06	0.000152	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—PSMD7—kidney cancer	2.09e-06	0.000151	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—CA9—kidney cancer	2.08e-06	0.00015	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—GSTM1—kidney cancer	2.06e-06	0.000148	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—POMC—kidney cancer	2.01e-06	0.000145	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—BCHE—kidney cancer	2e-06	0.000144	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—BCHE—kidney cancer	1.98e-06	0.000143	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—SLC5A5—kidney cancer	1.98e-06	0.000142	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—SLC5A5—kidney cancer	1.96e-06	0.000141	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—CYP1A1—kidney cancer	1.95e-06	0.000141	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—SLC2A1—kidney cancer	1.91e-06	0.000138	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—SLC2A1—kidney cancer	1.89e-06	0.000136	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	1.84e-06	0.000132	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—CRABP1—kidney cancer	1.77e-06	0.000128	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—ITPR2—kidney cancer	1.65e-06	0.000119	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—PTGS2—kidney cancer	1.6e-06	0.000116	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	1.6e-06	0.000115	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—GSTP1—kidney cancer	1.59e-06	0.000115	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—GSTP1—kidney cancer	1.58e-06	0.000114	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—ABCB1—kidney cancer	1.51e-06	0.000109	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—ACHE—kidney cancer	1.5e-06	0.000108	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—GSTT1—kidney cancer	1.5e-06	0.000108	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—ABCB1—kidney cancer	1.49e-06	0.000108	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—GSTM1—kidney cancer	1.46e-06	0.000105	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—POMC—kidney cancer	1.45e-06	0.000105	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—GSTM1—kidney cancer	1.45e-06	0.000105	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—SCARB1—kidney cancer	1.42e-06	0.000102	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—PTGS1—kidney cancer	1.41e-06	0.000101	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—PTEN—kidney cancer	1.4e-06	0.000101	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—CYP1A1—kidney cancer	1.39e-06	0.0001	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—PSMD7—kidney cancer	1.38e-06	9.95e-05	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—CYP1A1—kidney cancer	1.37e-06	9.91e-05	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—BCHE—kidney cancer	1.31e-06	9.43e-05	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—SLC5A5—kidney cancer	1.29e-06	9.31e-05	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—SLC2A1—kidney cancer	1.25e-06	8.99e-05	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—PTGS2—kidney cancer	1.16e-06	8.36e-05	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	1.13e-06	8.14e-05	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—GSTP1—kidney cancer	1.04e-06	7.5e-05	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—POMC—kidney cancer	1.03e-06	7.45e-05	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—POMC—kidney cancer	1.02e-06	7.39e-05	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—PTEN—kidney cancer	1.01e-06	7.29e-05	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—PIK3CA—kidney cancer	9.87e-07	7.12e-05	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—ABCB1—kidney cancer	9.85e-07	7.1e-05	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—GSTM1—kidney cancer	9.56e-07	6.89e-05	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—CYP1A1—kidney cancer	9.07e-07	6.54e-05	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—PTGS2—kidney cancer	8.25e-07	5.94e-05	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—PTGS2—kidney cancer	8.17e-07	5.89e-05	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—PTEN—kidney cancer	7.19e-07	5.18e-05	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—PIK3CA—kidney cancer	7.13e-07	5.14e-05	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—PTEN—kidney cancer	7.13e-07	5.14e-05	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—POMC—kidney cancer	6.76e-07	4.87e-05	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—PTGS2—kidney cancer	5.39e-07	3.89e-05	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—PIK3CA—kidney cancer	5.07e-07	3.66e-05	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—PIK3CA—kidney cancer	5.03e-07	3.63e-05	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—PTEN—kidney cancer	4.7e-07	3.39e-05	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—PIK3CA—kidney cancer	3.32e-07	2.39e-05	CbGpPWpGaD
